CATALOGO DEI PRODOTTI DELLA RICERCA

UGEL, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.551
NA - Nord America 5.332
AS - Asia 3.507
SA - Sud America 503
Continente sconosciuto - Info sul continente non disponibili 229
AF - Africa 127
OC - Oceania 23
Totale 15.272
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.184
RU - Federazione Russa 2.092
SG - Singapore 1.316
IT - Italia 993
CN - Cina 933
GB - Regno Unito 880
BR - Brasile 391
DE - Germania 370
VN - Vietnam 367
HK - Hong Kong 352
FI - Finlandia 229
FR - Francia 213
IE - Irlanda 206
SE - Svezia 202
BD - Bangladesh 117
KR - Corea 103
NL - Olanda 103
IN - India 68
CA - Canada 65
ID - Indonesia 53
UA - Ucraina 51
MX - Messico 44
JP - Giappone 39
TR - Turchia 39
AT - Austria 38
AR - Argentina 37
ZA - Sudafrica 33
ES - Italia 32
BE - Belgio 30
PL - Polonia 26
NG - Nigeria 24
IQ - Iraq 21
AU - Australia 20
CO - Colombia 20
TG - Togo 18
CZ - Repubblica Ceca 17
BJ - Benin 15
PK - Pakistan 14
SA - Arabia Saudita 14
EC - Ecuador 13
VE - Venezuela 13
JM - Giamaica 12
MA - Marocco 10
PH - Filippine 10
PY - Paraguay 10
CH - Svizzera 9
IL - Israele 9
LT - Lituania 8
PT - Portogallo 8
TN - Tunisia 8
PE - Perù 7
CL - Cile 6
CR - Costa Rica 6
EG - Egitto 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
MY - Malesia 5
PS - Palestinian Territory 5
CY - Cipro 4
HR - Croazia 4
IR - Iran 4
OM - Oman 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
HU - Ungheria 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PA - Panama 3
TW - Taiwan 3
BG - Bulgaria 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
JO - Giordania 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NP - Nepal 2
SI - Slovenia 2
SV - El Salvador 2
UZ - Uzbekistan 2
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
EE - Estonia 1
Totale 15.029
Salva come PNG Salva come JPEG
Città #
Moscow 763
Ashburn 744
Southend 724
Singapore 656
San Jose 542
Verona 494
Chandler 408
Dallas 406
Hong Kong 338
Council Bluffs 235
Munich 207
New York 202
Beijing 199
Dublin 198
Jacksonville 188
Woodbridge 159
The Dalles 156
Ann Arbor 141
Los Angeles 126
Helsinki 107
Houston 100
Ho Chi Minh City 89
Redmond 84
Hanoi 64
Lawrence 61
Princeton 61
Jinan 58
Wilmington 58
Santa Clara 55
Milan 54
Shenyang 51
Buffalo 50
Orem 49
Nanjing 42
São Paulo 42
Jakarta 41
London 40
Redondo Beach 40
Turku 36
Dong Ket 34
Tokyo 34
Amsterdam 32
Denver 31
Brussels 30
Chicago 30
Columbus 29
Lappeenranta 28
Tianjin 28
Brooklyn 26
Frankfurt am Main 26
Johannesburg 26
Montreal 26
Atlanta 25
Phoenix 25
Zhengzhou 25
Abuja 23
Washington 23
Chennai 22
Hebei 22
Mexico City 22
Nanchang 21
Vienna 21
Ningbo 20
Rome 20
Warsaw 20
Haiphong 19
Hangzhou 19
Haikou 18
Lomé 18
Stockholm 18
Toronto 18
Guangzhou 17
Nuremberg 17
Redwood City 17
Sindelfingen 17
Manchester 16
Changsha 15
Cotonou 15
Paris 15
Seattle 15
Seoul 15
Boston 14
Da Nang 14
Jiaxing 14
Poplar 14
San Francisco 13
Boydton 12
Sydney 12
Ankara 11
Boardman 11
Madrid 11
Norwalk 11
Padova 11
Rio de Janeiro 11
St Louis 11
Taiyuan 11
Baghdad 10
Bologna 10
Querétaro 10
Sant'Ambrogio di Valpolicella 10
Totale 9.227
Salva come PNG Salva come JPEG
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 314
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 305
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 296
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 289
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 288
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 270
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 260
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 259
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 256
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 256
Deciphering the state of immune silence in fatal COVID-19 patients 242
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. 241
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 233
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 230
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 220
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 220
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 214
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 213
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 210
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 202
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 202
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 197
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 197
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation 196
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 196
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 184
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 183
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 179
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 177
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 174
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 171
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. 171
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 171
The Endless Saga of Monocyte Diversity 167
Anti-telomerase T cells adoptive transfer 167
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 167
Local ablation disrupts immune evasion in pancreatic cancer 164
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 164
Circulating IgG4+ Plasmablast Count as a Diagnostic Tool in Autoimmune Pancreatitis 162
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. 162
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 161
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 160
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis 160
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. 160
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. 159
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 155
The Engagement Between MDSCs and Metastases: Partners in Crime 151
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies 149
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 145
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment 144
HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development 142
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature 141
Therapeutic targeting of myeloid-derived suppressor cells. 140
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 140
Role of arginine metabolism in immunity and immunopathology. 139
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells 138
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 137
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 134
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 133
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 133
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. 133
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. 133
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 132
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines 132
T-cell tracking using Cerenkov and radioluminescence imaging 132
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. 130
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 130
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 129
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer 128
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 126
Phenotypical Characterization and Isolation of Tumor-Derived Mouse Myeloid-Derived Suppressor Cells 124
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 122
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells 119
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO. 119
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade 119
Immune-guided therapy of COVID-19. 119
Moonlighting Proteins Are Important Players in Cancer Immunology 115
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment 115
Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound 113
Tumor-Induced Myeloid-Derived Suppressor Cells 111
Monocytes in the Tumor Microenvironment 108
The dark side of tumor-associated endothelial cells 107
HER2 Aberrations in NSCLC: So Close Yet So Far 101
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy 99
GateMeClass: Gate Mining and Classification of cytometry data 98
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 95
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells 95
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 90
B-CELL RECEPTOR SIGNALING ACTIVITY IDENTIFIES PATIENTS WITH MANTLE CELL LYMPHOMA AT HIGHER RISK OF PROGRESSION 90
Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines 88
Pre-diagnostic prognostic value of leukocytes count and neutrophil-to-lymphocyte ratio in patients who develop colorectal cancer 75
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 72
A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2- ORCHESTRA Project 63
Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trial 40
Corneal regenerative contribution of endogenous and grafted limbal-corneal cells in a mouse model of simple limbal-corneal epithelial transplantation 35
c-FLIP as a master regulator of immune homeostasis and disease mechanisms 18
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to Kras G12D Inhibition in Pancreatic Cancer 10
Design, Synthesis, and Structural Evolution of Pseudo-Natural Product IDO1 Inhibitors and Degraders 8
Timing Matters: Effectiveness of Compressive Garments on Recovery in Trail Runners 7
Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacy 2
Totale 15.272
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.553
article - articoli 48.543
book - libri 0
conference - conferenze 1.744
curatela - curatele 0
other - altro 1.718
patent - brevetti 0
selected - selezionate 0
volume - volumi 548
Totale 105.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022515 0 152 37 21 18 12 17 38 49 17 41 113
2022/20231.268 72 165 105 221 102 310 23 71 130 8 38 23
2023/2024921 34 51 63 89 121 188 66 65 15 70 131 28
2024/20252.651 118 108 139 393 100 118 255 208 375 135 255 447
2025/20267.163 440 358 443 1.131 1.849 428 699 379 547 478 234 177
2026/2027337 122 215 0 0 0 0 0 0 0 0 0 0
Totale 15.272